Creatinine Clearance Calculator

Creatinine Clearance Calculator: Cockcroft-Gault and eGFR Guide for Kidney Function and Drug Dosing

Content by the Intelligent Calculator Health & Data Team, reviewed against our editorial policy. Meet the full Intelligent Calculator team.

This article covers how clinicians and patients measure and estimate kidney function — from formulas and calculators to drug-dosing adjustments and CKD staging. It is part of our health calculators collection alongside tools like our BMI calculator and ideal weight calculator.

Medical disclaimer: This calculator and article are for educational purposes only. They are not a substitute for professional clinical judgment. Always confirm dosing decisions with a pharmacist, physician, or current prescribing information.

What Is a Creatinine Clearance Calculator?

A creatinine clearance calculator is a tool that estimates how well your kidneys filter waste from your blood. It uses your age, sex, weight, and a blood test called serum creatinine to produce a number in milliliters per minute (mL/min).

Doctors and pharmacists use this number, called creatinine clearance (CrCl), mainly to set safe drug doses. It’s also called a kidney function calculator or renal function calculator.

This guide explains the Cockcroft-Gault formula behind the calculator, the related eGFR (estimated glomerular filtration rate) formula used for kidney disease staging, and how to read your results. It includes fully worked examples, reference ranges, and answers to the most common questions people search for.

Who Should Use This Calculator

• Clinical pharmacists adjusting drug doses for kidney-cleared medications.
• Nephrologists and primary care physicians staging chronic kidney disease (CKD) and tracking its progression.
• Oncologists calculating chemotherapy doses like carboplatin.
• Nurses and advanced practice providers screening patients before giving nephrotoxic drugs or contrast dye.
• Patients and caregivers who want to understand a lab result handed to them after a blood test.

Why This Matters

Kidney function testing isn’t just a number on a lab report. It directly affects medication safety.

An elderly patient can have a “normal” creatinine level and still have severely reduced kidney function, because low muscle mass keeps creatinine artificially low. Missing that distinction can lead to drug toxicity, longer hospital stays, or permanent kidney damage. That’s why clinicians calculate clearance instead of reading serum creatinine alone.

Kidney Function in Plain English

Your kidneys filter about 180 liters of blood every day. Glomerular Filtration Rate (GFR) measures how much of that fluid actually passes through the kidney’s filtering units per minute.

GFR is considered the single best marker of overall kidney health. But measuring it directly requires an invasive lab test, so in everyday practice, doctors estimate it using creatinine.

How Creatinine Is Made and Cleared

Creatinine is a waste product from muscle breakdown. Your muscles produce it at a fairly steady rate, and healthy kidneys filter it out of the blood and into urine.

In plain English: more muscle mass generally means more creatinine production, and healthy kidneys clear it at a predictable rate. That relationship is what makes creatinine useful as a kidney-function stand-in.

Why Creatinine Clearance Overestimates True GFR

Creatinine doesn’t leave the body through filtration alone. A small amount is also actively pushed out by the kidney’s tubules, a process called tubular secretion.

In summary: most of your calculated creatinine clearance reflects true kidney filtration, but 10 to 15% comes from a separate secretion process. As kidney function worsens, tubular secretion can rise to as much as 50% of total clearance, which makes calculated CrCl look better than the kidney’s real filtering ability. This gap is one reason CrCl and eGFR are not interchangeable — a distinction covered in Section 3.

Physiological Confounders (Risks to Watch For)

Several conditions distort a serum creatinine reading without changing true kidney function. Each deserves individual attention because misreading any one of them can lead to a wrong dose.

Cachexia and sarcopenia. Severe muscle wasting — from anorexia, advanced age, or chronic illness — lowers creatinine production. This makes serum creatinine deceptively low, masking real kidney damage unless clinicians adjust for muscle loss or use Cystatin C instead.

Pregnancy. Normal pregnancy triggers gestational hyperfiltration, increasing GFR by roughly 40–50%. A creatinine level of 0.9 mg/dL, normal outside pregnancy, can signal kidney dysfunction during pregnancy.

Amputation and neuromuscular disease. Losing limb mass, or having a condition like muscular dystrophy, reduces total creatinine production the same way cachexia does. Clinicians must adjust body weight calculations or use a direct clearance test instead.

Diet and drug interference. Eating cooked red meat raises serum creatinine for up to 12 hours without changing true GFR. Drugs like trimethoprim and cimetidine block tubular secretion, artificially raising creatinine and making kidney function look worse than it is.

In plain terms: the left column of conditions make a patient look healthier than they are, and the right column make them look sicker than they are. Both distort dosing decisions if left uncorrected.

Creatinine Clearance vs. eGFR vs. GFR: Frequently Confused Terms

These three terms get mixed up constantly, so here’s a direct comparison.

In summary: CrCl is the number pharmacists use to set your dose, while eGFR is the number doctors use to stage kidney disease. They are related but not the same, and using one where the other belongs can cause dosing errors.

A Note on “Creatinine Level” vs. “Creatinine Clearance”

A serum creatinine level is a single lab value — a snapshot of how much creatinine is floating in your blood right now. Creatinine clearance is a calculated rate — how fast your kidneys can remove that creatinine over time. A high creatinine level and a low creatinine clearance describe the same underlying problem from two different angles, but they are not the same measurement.

Creatinine vs. Creatine: Don’t Confuse Them

Creatinine and creatine are frequently mixed up in search and in casual conversation, but they are different substances. Creatine is a compound found in muscle and sold as a dietary supplement. Creatinine is the waste byproduct left over after creatine phosphate is broken down in muscle. Taking creatine supplements can raise your serum creatinine level and make kidney function look slightly worse on paper, without actually harming your kidneys — this is a well-documented confounder pharmacists check for before adjusting a dose.

Normal Creatinine Clearance and eGFR Reference Ranges

People often want a direct number before reading any formula, so here it is.

In plain language: an eGFR of 90 or above usually means normal kidney function, while adult CrCl in the high double digits to low triple digits is typical for healthy kidneys. Exact cutoffs vary slightly by lab and formula, so always check the reference range printed on your own lab report.

Age-Related Decline (Illustrative)

Kidney filtration naturally slows with age. Starting around age 40, GFR drops by roughly 0.75 to 1.0 mL/min/1.73 m² per year due to a process called nephrosclerosis (age-related kidney tissue changes).

These figures are illustrative averages derived from the typical age-related decline rate, not a validated reference table. Individual results vary widely, and a lower eGFR in an older adult does not automatically mean disease — it must be interpreted alongside symptoms and trends over time.

How to Calculate Creatinine Clearance: The Cockcroft-Gault Equation

Published in 1976 by Donald W. Cockcroft and Henry T. Gault, this formula is still the standard the FDA uses for drug dosage adjustments.

Conventional Units (mg/dL)

Men: CrCl = [(140 − Age) × Weight (kg)] ÷ [72 × Serum Creatinine (mg/dL)]

Women: CrCl = [(140 − Age) × Weight (kg)] ÷ [72 × Serum Creatinine (mg/dL)] × 0.85

SI Units (µmol/L)

Men: CrCl = [(140 − Age) × Weight (kg) × 1.23] ÷ Serum Creatinine (µmol/L)

Women: CrCl = [(140 − Age) × Weight (kg) × 1.04] ÷ Serum Creatinine (µmol/L)

In plain English: older, lighter, or higher-creatinine patients get lower clearance estimates. The formula essentially rewards younger age, more weight (up to a point), and lower creatinine with a higher clearance number.

Worked SI-Unit Example

For illustration — a representative scenario, not a real patient. A 55-year-old man weighs 80 kg with serum creatinine of 100 µmol/L.

CrCl = [(140 − 55) × 80 × 1.23] ÷ 100 = (85 × 80 × 1.23) ÷ 100 = 8,364 ÷ 100 = 83.6 mL/min

This gives international clinicians working in µmol/L the same worked-example clarity that mg/dL users get elsewhere in this guide.

Why the Female Correction Factor Is 0.85

The 0.85 multiplier exists because, on average, women have a lower proportion of muscle mass relative to total body weight than men do. Since creatinine comes from muscle breakdown, women naturally produce less of it for the same body weight. Without this adjustment, the raw formula would overestimate clearance in female patients.

Input Parameters Explained

• Age (18–110 years): Clearance naturally declines with age due to nephron loss.
• Sex: Determines whether the 0.85 correction factor applies.
• Weight (kg): Choosing actual, ideal, or adjusted body weight (Section 6) is critical — using the wrong one causes dosing errors.
• Serum creatinine: Reported in mg/dL in the US and µmol/L in most other countries.

Assumptions and Limitations

• Assumes stable, steady-state kidney function. It is not valid in acute kidney injury (AKI) — serum creatinine lags behind real-time filtration changes.
• Assumes typical muscle composition, so it overestimates clearance in cachectic patients and underestimates it in very muscular patients.
• Derived from a cohort of 248 male patients (Cockcroft & Gault, Nephron, 1976); the female correction factor was estimated rather than derived from a matched female cohort of the same size.
• The formula’s overall accuracy — often summarized in nephrology literature using a “P30” metric (the percentage of estimates falling within 30% of measured GFR) — varies by population. A specific P30 percentage is not stated here because a verified, current figure was not available in our source material; readers citing this statistic should consult a primary nephrology reference.

Choosing the Right Body Weight: IBW, AdjBW, and ABW

Using raw total body weight in an obese patient overestimates clearance, because fat tissue doesn’t produce creatinine the way muscle does. Selecting the right weight metric is one of the most common places dosing goes wrong.

Ideal Body Weight (Devine Formula)

Men: IBW = 50.0 kg + 2.3 kg × (height in inches − 60) Women: IBW = 45.5 kg + 2.3 kg × (height in inches − 60)

For height in centimeters, first divide by 2.54 to get inches. Our ideal weight calculator uses this same Devine formula if you want to check IBW on its own.

Adjusted Body Weight

AdjBW = IBW + 0.40 × (Actual Body Weight − IBW)

Weight Selection Algorithm

In summary: thinner patients get their real weight, obese patients get a blended “adjusted” weight, and everyone else can reasonably use either — this single decision changes a calculated dose more than almost any other input in the formula.

The 24-Hour Urine Creatinine Clearance Test

When formulas are unreliable — severe malnutrition, amputation, or unusual diets — a 24-hour urine collection gives a direct, measured result instead of an estimate.

Formula: CrCl (mL/min) = (Urine Creatinine × Urine Volume) ÷ (Plasma Creatinine × 1,440 minutes)

Checking Collection Adequacy

A common source of error is an incomplete or overextended collection. Clinicians verify accuracy by checking total daily creatinine excretion against expected ranges.

In plain terms: results below these ranges usually mean a missed urine collection (under-collection), and results above suggest the sample ran longer than 24 hours or the patient consumed extra creatinine from diet or supplements.

Normalizing to Body Surface Area

To compare a measured clearance directly to eGFR staging values, normalize it to a standard 1.73 m² body surface area (BSA), calculated with the DuBois formula:

BSA = 0.007184 × Weight (kg)^0.425 × Height (cm)^0.725 Normalized CrCl = CrCl × (1.73 ÷ BSA)

eGFR and the CKD-EPI Equation: Staging Kidney Disease

While CrCl drives drug dosing, eGFR is the standard for staging chronic kidney disease.

CKD-EPI 2021 (Race-Free) Equation

• Women: κ = 0.7, α = −0.241
• Men: κ = 0.9, α = −0.302

Race-Based eGFR History and the 2021 Refinement

Earlier eGFR equations, including the original CKD-EPI (2009) and MDRD formulas, included a coefficient that adjusted results upward for patients identified as Black. That coefficient was based on population-level assumptions about muscle mass rather than a direct biological measurement.

In 2021, a joint task force from the National Kidney Foundation and the American Society of Nephrology recommended removing the race coefficient. The concern was that the adjustment could make kidney function appear better than it was for Black patients, potentially delaying specialist referrals, dialysis planning, or transplant eligibility. The CKD-EPI 2021 equation shown above reflects that race-free refinement and is now the preferred staging formula.

The MDRD Study Equation (Historical Reference)

Before CKD-EPI, the MDRD Study equation was the standard staging formula. It is shown here in full for reference, since many older lab reports and legacy charts still use it:

eGFR = 175 × (Scr)^−1.154 × (Age)^−0.203 × [0.742 if female] × [1.212 if historically classified as Black]

MDRD tends to underestimate true GFR at values above 60 mL/min/1.73 m², which is one reason CKD-EPI replaced it as the preferred formula.

Combined Creatinine-Cystatin C CKD-EPI Equation (2021)

A separate 2021 CKD-EPI equation combines both serum creatinine and Cystatin C into a single estimate. Because it draws on two independent biomarkers with different confounders, it is considered the most accurate non-invasive eGFR estimate available, and it’s especially useful when creatinine-only results are questionable due to low muscle mass. The combined equation uses both the creatinine-based and Cystatin C-based coefficients in a single weighted formula; because the exact published coefficient set is lengthy and easy to transcribe incorrectly, readers who need to implement it directly should confirm the current coefficients against the original 2021 CKD-EPI publication before clinical use.

The Gold-Standard Reference: Iohexol and Inulin Clearance

Both CrCl and eGFR are estimates. The true reference standard for measuring GFR directly uses an exogenous filtration marker — a substance infused into the bloodstream that is cleared purely by filtration, with no tubular secretion or reabsorption to distort the result. Inulin clearance was the original gold standard; iohexol clearance is now more commonly used in research and select clinical situations, such as living kidney donor evaluation or precision chemotherapy dosing, because it’s easier to administer and measure than inulin.

KDIGO CKD Staging

The Kidney Disease: Improving Global Outcomes (KDIGO) framework stages chronic kidney disease using eGFR.

In summary: an eGFR of 90 or above is normal kidney function (Stage G1), while an eGFR below 15 mL/min/1.73 m² indicates kidney failure requiring renal replacement therapy (Stage G5). CKD staging also incorporates albuminuria categories (A1–A3), which are outside the scope of this calculator guide.

Cystatin C and the Kidney Failure Risk Equation (KFRE)

Cystatin C is a protein produced by nearly every cell in the body at a steady rate, filtered by the kidneys, and unaffected by muscle mass, age, or diet. That makes it a useful backup marker when creatinine is unreliable — for example, in cachectic or amputee patients.

CKD-EPI Cystatin C Equation (2012)

eGFRcys = 133 × min(CysC/0.8, 1)^−0.499 × max(CysC/0.8, 1)^−1.328 × 0.996^Age × [0.932 if female]

Where CysC is serum Cystatin C in mg/L.

The Kidney Failure Risk Equation

The KFRE predicts a CKD patient’s probability of progressing to end-stage kidney disease within 2 or 5 years, using age, sex, eGFR, and urine albumin-to-creatinine ratio (uACR).

Linear Predictor = −0.2201 × (Age/10 − 7.036) + 0.2467 × (Male − 0.5642) − 0.5567 × (eGFR/5 − 7.222) + 0.4510 × (ln(uACR) − 5.137)

Risk = 1 − S(t)^exp(Linear Predictor), where S(5 yr) = 0.9365 for North American populations.

Worked KFRE Example

For illustration — a representative scenario, not a real patient. A 65-year-old man has an eGFR of 25 mL/min/1.73 m² and a uACR of 300 mg/g.

1. Age term: (65/10 − 7.036) × −0.2201 = (−0.536) × −0.2201 = 0.118
2. Sex term: (1 − 0.5642) × 0.2467 = 0.108
3. eGFR term: (25/5 − 7.222) × −0.5567 = (−2.222) × −0.5567 = 1.237
4. uACR term: (ln(300) − 5.137) × 0.4510 = (5.704 − 5.137) × 0.4510 = 0.256

Linear Predictor ≈ 0.118 + 0.108 + 1.237 + 0.256 = 1.719

5-Year Risk = 1 − 0.9365^exp(1.719) ≈ 1 − 0.9365^5.58 ≈ 31%

This patient has an approximate 31% five-year risk of progressing to kidney failure — a result that would typically prompt an urgent nephrology referral.

How This Creatinine Clearance Calculator Works

The calculator above uses the following fields and logic behind the scenes.

Inputs: age, sex, height, weight, and serum creatinine, with a toggle for mg/dL or µmol/L units. Every field is validated in real time — the calculator won’t return a result if a value falls outside plausible physiological ranges (for example, age 18–110, weight 20–300 kg, or serum creatinine 0.1–20 mg/dL).

Calculation logic: once valid data is entered, the tool computes Ideal Body Weight using the Devine formula, compares it to actual body weight, and automatically selects Actual, Ideal, or Adjusted Body Weight following the algorithm in Section 6. It then runs the Cockcroft-Gault formula using that selected weight.

Output: the result displays CrCl in mL/min, along with the auto-selected weight category shown transparently so you can verify the logic rather than treating it as a black box. Where relevant, results can be compared side-by-side with a CKD-EPI eGFR estimate to illustrate why the two numbers differ.

Real-time behavior: the calculator recalculates instantly as you adjust any input, letting you compare, for example, how a 10 kg weight change or a unit switch affects the final clearance estimate.

Creatinine Clearance and Drug Dosing: Clinical Applications

Adjusting drug doses for kidney function prevents medication accumulation, toxicity, and organ damage. Here’s the general decision path clinicians follow.

In summary: as CrCl falls, doses typically shrink or dosing intervals stretch, and below 15 mL/min most kidney-cleared drugs require specialist input rather than a standard adjustment.

High-Risk Renally Cleared Medications

In plain terms: this table restates that kidney-cleared drugs generally need smaller doses, longer intervals, or closer monitoring as clearance drops — but exact cutoffs change as prescribing labels are updated, so always verify against current information before adjusting a real dose.

Dialysis and Severe Renal Impairment Dosing Considerations

Standard clearance formulas assume functioning kidneys are doing the clearing. Once a patient starts dialysis, that assumption breaks down, and dosing shifts to a different framework entirely.

Hemodialysis. Drug removal during hemodialysis depends on the drug’s molecular size, protein binding, and water solubility — not on a CrCl number. Many drugs need a supplemental dose given after each dialysis session to replace what the dialysis filter removed, in addition to any maintenance dose based on residual kidney function.

Peritoneal dialysis. Clearance happens continuously through the peritoneal membrane rather than in discrete sessions. Drug removal is generally slower and less predictable than hemodialysis, and dosing typically accounts for both residual native kidney function and ongoing peritoneal clearance.

Because dialysis dosing depends heavily on the specific drug and dialysis modality, it should be managed with a renal drug dosing reference or a nephrology/pharmacy specialist rather than estimated from a standard CrCl calculator.

Pediatric Kidney Function: The Bedside Schwartz Equation

Cockcroft-Gault doesn’t work in children, because their skeletal proportions and muscle-to-mass ratios change continuously as they grow.

Bedside Schwartz Equation (2009 Standard)

eGFR (mL/min/1.73 m²) = (0.413 × Height in cm) ÷ Serum Creatinine (mg/dL)

This race- and sex-neutral formula is validated for children ages 1 to 18 using modern, standardized creatinine assays.

Original Schwartz Equation (Historical k-values)

eGFR = (k × Height in cm) ÷ Serum Creatinine (mg/dL)

In summary: pediatric formulas swap weight for height as the muscle-mass proxy, and the constant (k) changes with age and sex because muscle proportion changes so much during growth.

Carboplatin Dosing With the Calvert Formula

Dosing chemotherapy purely by body surface area causes unpredictable toxicity, because kidney function varies so much between patients of the same size. The Calvert Formula solves for the exact carboplatin dose needed to hit a target drug exposure.

Total Carboplatin Dose (mg) = Target AUC (mg·min/mL) × (GFR + 25)

Clinical guidelines:

• Calculated Cockcroft-Gault CrCl is routinely substituted for true GFR in practice.
• To prevent accidental overdose in patients with unusually high filtration, oncology guidelines cap the GFR input at 125 mL/min.
• Maximum dose formula: Target AUC × (125 + 25). For a target AUC of 6, the maximum allowable dose is 6 × 150 = 900 mg.

Practical Examples: Step-by-Step Clinical Scenarios

All patient scenarios below are illustrative — representative cases constructed to demonstrate the calculations, not real patients.

Scenario 1: Obese Patient, Rivaroxaban Dosing

A 68-year-old man is being started on rivaroxaban for atrial fibrillation. Height 177.8 cm, weight 110 kg (BMI 34.8, Class II obesity), serum creatinine 1.6 mg/dL.

1. IBW = 50.0 + 2.3 × (70 − 60) = 73.0 kg
2. ABW ÷ IBW = 110 ÷ 73.0 = 150.7% of IBW → use Adjusted Body Weight
3. AdjBW = 73.0 + 0.40 × (110 − 73.0) = 87.8 kg
4. CrCl (using AdjBW) = [(140 − 68) × 87.8] ÷ (72 × 1.6) = 6,321.6 ÷ 115.2 = 54.9 mL/min
5. For comparison, using raw weight instead: CrCl = [(140 − 68) × 110] ÷ (72 × 1.6) = 68.8 mL/min

Outcome: Rivaroxaban labeling calls for a dose reduction from 20 mg to 15 mg daily once CrCl drops below 50 mL/min. The correctly adjusted result (54.9 mL/min) allows a standard starting dose, but the raw-weight number (68.8 mL/min) would have masked this patient’s borderline renal reserve — a difference that matters for close monitoring going forward.

Scenario 2: Frail Elderly Patient, Vancomycin Dosing

An 82-year-old woman with a urinary tract infection needs IV vancomycin. Height 160 cm, weight 41 kg (severely underweight), serum creatinine 0.5 mg/dL.

1. IBW = 45.5 + 2.3 × (63 − 60) = 52.4 kg → since actual weight is below IBW, use Actual Body Weight
2. Unadjusted CrCl = [(140 − 82) × 41] ÷ (72 × 0.5) × 0.85 = (2,378 ÷ 36) × 0.85 = 56.1 mL/min
3. Because this low creatinine likely reflects muscle wasting rather than healthy kidneys, protocol rounds serum creatinine up to a floor of 0.8 mg/dL: CrCl (adjusted) = [(140 − 82) × 41] ÷ (72 × 0.8) × 0.85 = (2,378 ÷ 57.6) × 0.85 = 35.1 mL/min

Outcome: Using the adjusted estimate, the pharmacist extends vancomycin dosing from every 12 hours to every 24 hours, preventing drug accumulation and reducing the risk of vancomycin-related kidney injury.

Scenario 3: Chemotherapy Dosing, Calvert Formula

A 62-year-old woman with recurrent ovarian cancer is starting carboplatin. Height 165 cm, weight 65 kg (IBW 57 kg), serum creatinine 1.1 mg/dL, target AUC 5 mg·min/mL.

1. CrCl = [(140 − 62) × 65] ÷ (72 × 1.1) × 0.85 = (5,070 ÷ 79.2) × 0.85 = 54.4 mL/min
2. Total Dose = Target AUC × (CrCl + 25) = 5 × 79.4 = 397 mg

Outcome: The patient receives an exact 397 mg intravenous dose, tailored to achieve target tumor exposure while limiting bone marrow suppression.

Method Comparison Tables

Cockcroft-Gault vs. MDRD vs. CKD-EPI

In summary: Cockcroft-Gault is the dosing formula, CKD-EPI 2021 is the current staging formula, and MDRD is a legacy formula you’ll still see on older lab reports and chart histories.

BUN-to-Creatinine Ratio Interpretation

In plain terms: a high ratio usually points to a circulation or hydration problem rather than direct kidney damage, while a low ratio points away from the kidneys entirely, toward diet or liver function.

Common Creatinine Clearance Calculation Mistakes

• Mixing units. Using a µmol/L value in a mg/dL formula (or vice versa) produces a result off by a factor of roughly 88.4. Always confirm which unit your lab uses.
• Forgetting the 0.85 female multiplier. Skipping this factor overestimates clearance in female patients.
• Using actual body weight in obese patients. This overestimates clearance because fat tissue contributes little to creatinine handling — use Adjusted Body Weight instead (Section 6).
• Applying Cockcroft-Gault in acute kidney injury. The formula assumes steady-state creatinine; in AKI, it will overestimate true function.
• Treating eGFR and CrCl as interchangeable. eGFR is normalized to body surface area; CrCl is not. Swapping one for the other in a dosing calculation can misjudge the correct dose.
• Missing collection time on 24-hour urine tests. A single missed void skews the result low; collecting past 24 hours skews it high.

Pro tip: whenever a serum creatinine looks unusually low in a frail or elderly patient, treat it as a red flag for muscle wasting rather than reassurance about kidney health, and consider a Cystatin C check.

What This Number Means If You’re Not a Clinician

If a doctor hands you a lab report with “eGFR” or “creatinine clearance” on it, here’s the short version.

eGFR tells you roughly how well your kidneys are filtering blood, compared to a healthy young adult. Numbers of 90 and above are typically normal. Numbers under 60 for three months or more suggest chronic kidney disease and usually mean your doctor wants to monitor you or run more tests.

Creatinine clearance is a related but separate number, mostly used to figure out safe medication doses rather than to diagnose kidney disease on its own.

One low result usually isn’t an emergency, but it’s worth asking your doctor whether it’s a new change or a stable, expected value for your age. Dehydration, recent heavy exercise, or a high-protein meal before the blood draw can all temporarily affect the number — which is also why intense workouts can raise creatinine (from increased muscle breakdown) without reflecting any real kidney problem. Staying reasonably hydrated, tracked with a tool like our daily water intake calculator, supports accurate testing conditions, though it won’t meaningfully change an underlying chronic result.

Interpreting a Single eGFR Result Without a Baseline

A single eGFR reading tells you where kidney function stands right now, but not whether it’s stable, improving, or declining. Without a prior result to compare against, it’s hard to know if a below-normal number reflects long-standing chronic kidney disease or a new, acute drop that needs urgent attention.

Acute kidney injury develops over hours to days and is often reversible with prompt treatment. Chronic kidney disease develops over months to years and is generally managed rather than reversed. Because a first-time low eGFR could be either, clinicians typically repeat testing within days to weeks (sooner if the patient is acutely ill) to see the trend before deciding which category applies.

Glossary of Renal Function Terms

• GFR (Glomerular Filtration Rate): The true rate at which the kidneys filter blood, considered the gold-standard measure of kidney function.
• CrCl (Creatinine Clearance): An estimate of kidney filtration based on how quickly the body clears creatinine, used mainly for drug dosing.
• eGFR (estimated GFR): A population-formula estimate of GFR, normalized to standard body size, used mainly for CKD staging.
• BUN (Blood Urea Nitrogen): A blood test measuring urea, another waste product filtered by the kidneys, often compared against creatinine.
• Azotemia: An abnormal buildup of nitrogen waste products (like urea and creatinine) in the blood.
• Nephrosclerosis: Age- and hypertension-related hardening of small kidney blood vessels, a common cause of gradual GFR decline.
• Tubular Secretion: The active process by which the kidney’s tubules push extra creatinine into urine, on top of what’s filtered.
• Cystatin C: A protein-based kidney function marker unaffected by muscle mass, used as a backup or confirmatory test to creatinine.

Frequently Asked Questions

What is the primary difference between Creatinine Clearance (CrCl) and estimated Glomerular Filtration Rate (eGFR)?

Creatinine Clearance measures the total rate of creatinine removed by both glomerular filtration and active tubular secretion, reported as an absolute rate in mL/min. eGFR uses population formulas normalized to a standard 1.73 m² body surface area and reported as mL/min/1.73 m². eGFR is preferred for staging chronic kidney disease, while Cockcroft-Gault CrCl remains the standard for adjusting medication doses under FDA labeling guidance.

Why is Cockcroft-Gault still used for drug dosing instead of modern eGFR equations?

Historical FDA drug approval guidelines required manufacturers to use the Cockcroft-Gault equation to set renal dosing thresholds during clinical trials, so most drug labels are calibrated to absolute CrCl in mL/min. The FDA updated its guidance in 2010 to allow eGFR-based dosing, but switching to a body-surface-area-normalized eGFR without un-normalizing it can cause dosing errors in patients whose body size differs significantly from the 1.73 m² standard.

Which body weight should be used in the Cockcroft-Gault equation for obese patients?

Use Adjusted Body Weight for patients whose total body weight exceeds 120% of their calculated Ideal Body Weight, or whose BMI is 30 kg/m² or higher. Using total actual weight overestimates clearance because fat tissue contributes minimally to creatinine production, while using Ideal Body Weight alone ignores the increased kidney size and blood flow associated with obesity, which can lead to under-dosing.

How does serum creatinine mask kidney failure in cachectic or elderly patients?

Creatinine production depends on total muscle mass. In elderly, malnourished, or cachectic patients, muscle loss reduces daily creatinine production, keeping serum creatinine artificially low and masking real kidney impairment. Clinicians evaluating frail patients with unexpectedly low creatinine should consider a Cystatin C test or a direct 24-hour urine collection to confirm true clearance.

Can Creatinine Clearance equations be used in Acute Kidney Injury (AKI)?

No. All estimated clearance formulas assume serum creatinine has reached a steady state. In acute kidney injury, filtration drops rapidly, but serum creatinine takes 24 to 48 hours to catch up and reflect the change. Calculating clearance during that lag overestimates true kidney function and can lead to unsafe drug doses.

What causes a 24-hour urine collection to be inaccurate?

The most common error is incomplete collection — missing even one urine void under-collects and artificially lowers the measured clearance. Collecting for longer than 24 hours has the opposite effect, overestimating clearance. Clinicians check collection accuracy against expected daily creatinine excretion ranges (20–25 mg/kg/day for adult men, 15–20 mg/kg/day for adult women).

Why does the Bedside Schwartz equation replace Cockcroft-Gault in pediatric patients?

Pediatric body proportions, skeletal growth, and muscle composition change continuously during childhood, which makes weight-based adult formulas inaccurate for children. The Bedside Schwartz equation uses height as a surrogate for growing muscle mass instead, giving a more age-appropriate estimate of pediatric kidney function.

What is a normal creatinine clearance level?

For most healthy adults, creatinine clearance commonly falls in the range of roughly 97–137 mL/min for men and 88–128 mL/min for women, though exact reference ranges vary by lab and formula. A related measure, eGFR, is generally considered normal at 90 mL/min/1.73 m² or above.

Is a creatinine clearance of 50 mL/min bad?

A creatinine clearance of 50 mL/min is below the typical adult reference range and would usually prompt at least a moderate drug dose reduction for kidney-cleared medications. Whether it represents a health concern on its own depends on the person’s age, baseline kidney function, and whether the value is stable or declining over time — that context is best assessed by a clinician.

How is creatinine clearance different from a simple creatinine blood test?

A simple creatinine blood test reports a single lab value — the amount of creatinine currently circulating in your blood. Creatinine clearance is a calculated rate that combines that lab value with age, sex, and weight to estimate how quickly your kidneys are removing creatinine over time, which makes it more useful for dosing decisions than the raw lab value alone.

Does drinking water affect creatinine clearance results?

Significant dehydration can temporarily reduce blood flow to the kidneys and slightly affect lab values, but ordinary hydration status has only a minor, short-term effect on a creatinine clearance calculation. It will not meaningfully change a result reflecting long-standing, chronic kidney function.

How often should creatinine clearance be recalculated during hospitalization?

There’s no single universal interval — it depends on how unstable the patient’s kidney function is. In critically ill or rapidly changing patients, clinicians often recheck creatinine and recalculate clearance daily; in stable patients on long-term therapy, recalculation might happen weekly or with each new lab draw. Because creatinine clearance formulas assume steady-state kidney function, more frequent recalculation is safer whenever a patient’s clinical status is changing quickly.

What is considered stage 3 kidney disease on the eGFR scale?

Stage 3 chronic kidney disease is split into two sub-stages: Stage 3a covers an eGFR of 45–59 mL/min/1.73 m², and Stage 3b covers 30–44 mL/min/1.73 m². Both generally call for treating complications and monitoring progression, per the KDIGO staging framework in Section 8.

Why do some drug labels use CrCl instead of eGFR?

Most kidney-cleared drug labels were calibrated using Cockcroft-Gault CrCl data from the clinical trials that supported their FDA approval, long before eGFR became the preferred staging metric. Because that historical calibration used unadjusted mL/min values, switching to a body-surface-area-normalized eGFR without adjustment risks miscalculating doses, especially in patients whose body size differs from the 1.73 m² standard.

Can creatinine clearance be estimated without a weight measurement?

No — weight is a required input in the Cockcroft-Gault equation, since it’s used as a proxy for muscle mass. Formulas that don’t require weight, such as certain eGFR equations, exist for staging purposes, but they are not a substitute for CrCl in most drug-dosing calculations, which specifically call for the weight-based Cockcroft-Gault result.

What’s the difference between creatine and creatinine?

Creatine is a naturally occurring compound in muscle, also sold as a dietary supplement to support exercise performance. Creatinine is the waste byproduct left over after creatine phosphate is broken down during normal muscle metabolism. Taking creatine supplements can raise a measured serum creatinine level and make kidney function estimates look slightly worse, without reflecting any actual change in kidney health — a distinction worth mentioning to your doctor if you take creatine supplements before a blood test.

Sources

• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
• Inker LA, et al. New creatinine- and cystatin C–based equations to estimate GFR without race. New England Journal of Medicine. 2021.
• Schwartz GJ, et al. New equations to estimate GFR in children with CKD (Bedside Schwartz). Journal of the American Society of Nephrology. 2009.
• Calvert AH, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. Journal of Clinical Oncology. 1989.
• Tangri N, et al. A predictive model for progression of chronic kidney disease to kidney failure (Kidney Failure Risk Equation). JAMA. 2011.
• Kidney Disease: Improving Global Outcomes (KDIGO). Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
• U.S. Food and Drug Administration. Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function.

Note: exact edition years, page numbers, and DOIs for the KDIGO and FDA guidance documents should be verified against the current published editions before this article is finalized, as guideline documents are updated periodically and specific citation details were not independently verified for this draft.

Conclusion

Creatinine clearance and eGFR answer two related but different questions: CrCl guides drug dosing, and eGFR stages chronic kidney disease. Getting the formula, the body weight metric, and the underlying confounders right — cachexia, pregnancy, amputation, or acute kidney injury — is what separates an accurate dose from a dangerous one.

This calculator automates the Cockcroft-Gault formula and its weight-selection logic, but the worked examples throughout this guide show exactly what’s happening behind that automation, so you can verify any result by hand. Whether you’re a clinician adjusting a real prescription or a patient trying to understand a lab report, the goal is the same: know what the number means before you act on it.